TNFRSF10B and melanoma: For example, a bi-specific melanoma-associated chondroitin sulfate proteoglycan (MCSP)—DR5 (TRAIL-R2) antibody has been produced that combines high affinity binding to melanoma cells with strong apoptosis-inducing potential (126).